Frequency and distribution of Alzheimer's disease in Europe: a collaborative study of 1980-1990 prevalence findings. The EURODEM-Prevalence Research Group
- PMID: 1952826
- DOI: 10.1002/ana.410300310
Frequency and distribution of Alzheimer's disease in Europe: a collaborative study of 1980-1990 prevalence findings. The EURODEM-Prevalence Research Group
Abstract
We reanalyzed and compared current prevalence estimates of Alzheimer's disease in Europe. Studies characterized as follows qualified for comparison: dementia defined by the Diagnostic and Statistical Manual for Mental Disorders, 3rd edition, or equivalent criteria; Alzheimer's disease diagnosed by the National Institute of Neurological and Communicative Disorders and Stroke-Alzheimer's Disease and Related Disorders Association or equivalent criteria; case-finding through direct individual examination; appropriate sample size; and inclusion of institutionalized persons. Of the 23 European surveys of dementia considered, six fulfilled the inclusion criteria. When age and sex were considered, there were no major geographic differences in the prevalence of Alzheimer's disease across Europe. Overall European prevalence (per 100 population) for the age groups 30 to 59, 60 to 69, 70 to 79, and 80 to 89 years was, respectively, 0.02, 0.3, 3.2, and 10.8. Prevalence increased exponentially with advancing age and, in some populations, was consistently higher in women. Prevalence remained stable over 15 years in one study.
Similar articles
-
The prevalence of vascular dementia in Europe: facts and fragments from 1980-1990 studies. EURODEM-Prevalence Research Group.Ann Neurol. 1991 Dec;30(6):817-24. doi: 10.1002/ana.410300611. Ann Neurol. 1991. PMID: 1838681
-
The prevalence of dementia and Alzheimer's disease in Shanghai, China: impact of age, gender, and education.Ann Neurol. 1990 Apr;27(4):428-37. doi: 10.1002/ana.410270412. Ann Neurol. 1990. PMID: 2353798
-
The need for a consensus in the use of assessment tools for Alzheimer's disease: the Feasibility Study (assessment tools for dementia in Alzheimer Centres across Europe), a European Alzheimer's Disease Consortium's (EADC) survey.Int J Geriatr Psychiatry. 2005 Aug;20(8):744-8. doi: 10.1002/gps.1355. Int J Geriatr Psychiatry. 2005. PMID: 16035121
-
Neuropsychiatric syndromes in dementia. Results from the European Alzheimer Disease Consortium: part I.Dement Geriatr Cogn Disord. 2007;24(6):457-63. doi: 10.1159/000110738. Epub 2007 Nov 7. Dement Geriatr Cogn Disord. 2007. PMID: 17986816 Review.
-
[Epidemiology of Alzheimer disease and related disorders].Med Sci (Paris). 2006 Mar;22(3):288-96. doi: 10.1051/medsci/2006223288. Med Sci (Paris). 2006. PMID: 16527211 Review. French.
Cited by
-
Molecular genetics of Alzheimer's disease.Curr Psychiatry Rep. 2004 Apr;6(2):125-33. doi: 10.1007/s11920-004-0052-6. Curr Psychiatry Rep. 2004. PMID: 15038915 Review.
-
Can estrogens prevent neurodegeneration?Drugs Aging. 1997 Aug;11(2):87-95. doi: 10.2165/00002512-199711020-00001. Drugs Aging. 1997. PMID: 9259172 Review.
-
Deaths attributable to Alzheimer's disease in the United States.Am J Public Health. 1999 Jan;89(1):90-2. doi: 10.2105/ajph.89.1.90. Am J Public Health. 1999. PMID: 9987474 Free PMC article.
-
Pharmacogenetic Study on the Impact of Rivastigmine Concerning Genetic Variants of A2M and IL-6 Genes on Iranian Alzheimer's Patients.Mol Neurobiol. 2016 Sep;53(7):4521-8. doi: 10.1007/s12035-015-9387-8. Epub 2015 Aug 21. Mol Neurobiol. 2016. PMID: 26289409
-
Calcium channel blockers and dementia.Br J Pharmacol. 2013 Jul;169(6):1203-10. doi: 10.1111/bph.12240. Br J Pharmacol. 2013. PMID: 23638877 Free PMC article. Review.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical